Outcome of cancer-associated venous thromboembolism is more favorable among patients with hematologic malignancies than in those with solid tumors

R Lecumberri, P Ruiz-Artacho, I Tzoran… - Thrombosis and …, 2022 - thieme-connect.com
Background The natural history of patients with hematologic cancer and venous
thromboembolism (VTE) has not been consistently evaluated. We aimed to compare the …
被引用次数：10 相关文章

Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid Tumors

R Lecumberri, P Ruiz-Artacho, I Tzoran… - Thrombosis and …, 2022 - thieme-connect.com
Background The natural history of patients with hematologic cancer and venous
thromboembolism (VTE) has not been consistently evaluated. We aimed to compare the …

Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid Tumors.

R Lecumberri, P Ruiz-Artacho, I Tzoran… - Thrombosis and …, 2022 - europepmc.org
Background The natural history of patients with hematologic cancer and venous
thromboembolism (VTE) has not been consistently evaluated. We aimed to compare the …

Outcome of Cancer-Associated Venous Thromboembolism Is More Favorable among Patients with Hematologic Malignancies than in Those with Solid Tumors

R Lecumberri, P Ruiz-Artacho… - Thrombosis and …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The natural history of patients with hematologic cancer and venous
thromboembolism (VTE) has not been consistently evaluated. We aimed to compare the …